SMis Clinical Trials in CNS

Venue: Copthorne Tara Hotel

Location: London, United Kingdom

Event Date/Time: Nov 05, 2012 End Date/Time: Nov 06, 2012
Report as Spam


With increasing average life expectancy, these wide range of disorders (from Alzheimer’s, to Parkinson’s, MS, dementia and depression), are becoming increasingly widespread in the population, creating an ever- greater need for new treatments and therapies.

Key reasons to attend:

• Learn of the latest drug developments combating the key diseases in CNS, from Alzheimer's and dementia, to depression and schizophrenia
• Discuss the cutting issues of the industry, from the ethics of outsourcing, to proving efficacy
• Explore the latest innovations in pre-clinical discovery, trial optimisation and biomarker identification
• Discover new ways to manage and adapt a clinical trial to ensure its success and efficiency
• Network with key members of the industry involved in every part of clinical trials: from bench to bedside


Scardsale Place, Kensington
United Kingdom

Additional Information

PLUS TWO INTERACTIVE HALF-DAY PRE-CONFERENCE WORKSHOPS Wednesday 7th November, Copthorne Tara Hotel, 2012 A: Ensuring efficiency and communication in partnerships within CNS clinical trials Lori Wright, President & CEO, Thievon-Wright Consulting Group Steve Satek, Senior Vice President, Thievon-Wright Consulting Group 8.30 – 12.30pm B: Ethical decision making in clinical drug development Michael Emanuel, Managing Director, SintoPharm 13.00 – 5.00pm